Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
AIDS Res Ther ; 21(1): 12, 2024 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-38429716

RESUMO

BACKGROUND: Increased incidence of lifestyle diseases as side-effects of antiretroviral therapy (ART) have been reported in people living with HIV (PLWH). Few studies have evaluated obesity and hidden obesity in Japanese PLWH and their association with ART. In order to provide more appropriate drug selection and lifestyle guidance, we investigated the relationship between the effects of HIV infection and ART on the body composition of Japanese PLWH. METHODS: PLWH who visited the outpatient clinic and had body composition measured using the body composition analyzer InBody 570 were included in this study. Medications, comorbidities, and blood test data were obtained. Body mass index (BMI), body fat percentage, and skeletal muscle mass index (SMI) were measured. RESULTS: In this study, 543 patients were included. Based on body shape, patients were classified into a thin group (13), normal weight group (14), hidden obesity group (158), apparent obesity group (14), and obesity group (218). Compared with the normal weight group, the hidden obesity group had a higher prevalence of comorbidities and a lower SMI. CONCLUSIONS: PLWH are more likely to have obesity than the general population, indicating that hidden obesity is common even among those with a normal BMI. It is important to measure body fat percentage along with body weight, as hidden obesity can be missed. Further investigation of the effects of ART on body composition is needed.


Assuntos
Infecções por HIV , Humanos , Infecções por HIV/complicações , Infecções por HIV/tratamento farmacológico , Infecções por HIV/epidemiologia , Obesidade/epidemiologia , Obesidade/complicações , Composição Corporal , Comorbidade , Índice de Massa Corporal
2.
Phys Rev Lett ; 124(20): 202501, 2020 May 22.
Artigo em Inglês | MEDLINE | ID: mdl-32501086

RESUMO

We measured missing mass spectrum of the ^{12}C(γ,p) reaction for the first time in coincidence with potential decay products from η^{'} bound nuclei. We tagged an (η+p) pair associated with the η^{'}N→ηN process in a nucleus. After applying kinematical selections to reduce backgrounds, no signal events were observed in the bound-state region. An upper limit of the signal cross section in the opening angle cosθ_{lab}^{ηp}<-0.9 was obtained to be 2.2 nb/sr at the 90% confidence level. It is compared with theoretical cross sections, whose normalization ambiguity is suppressed by measuring a quasifree η^{'} production rate. Our results indicate a small branching fraction of the η^{'}N→ηN process and/or a shallow η^{'}-nucleus potential.

4.
Appl Radiat Isot ; 65(1): 32-5, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-16908177

RESUMO

A technique for preparing nuclear reaction targets of various thicknesses was developed by using common filtration technique of hydroxide precipitates with a porous Al(2)O(3) membrane filter. Uniformity was found to be within a few % in each thickness. Durability for beam irradiation was also confirmed. The preparation procedure is convenient and the method is appropriate for several target materials, including not only precious materials but also radioactive materials with low contamination.


Assuntos
Óxido de Alumínio/química , Óxido de Alumínio/efeitos da radiação , Precipitação Fracionada , Íons Pesados , Física Nuclear/métodos , Ultrafiltração/métodos , Teste de Materiais
5.
Rev Sci Instrum ; 87(5): 053508, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-27250424

RESUMO

The nucleus (235m)U is an isomer with extremely low excitation energy (76.8 eV) and decays dominantly through the internal conversion (IC) process. Because outer-shell electrons are involved in the IC process, the decay constant of (235m)U depends on its chemical environment. We plan to study the deexcitation process of (235m)U by measuring the energy spectra of IC electrons in addition to the decay constants for various chemical forms. In this paper, the preparation method of (235m)U samples from (239)Pu by using alpha-recoil energy is reported. A Collection Apparatus for Recoil Products was fabricated, and then collection efficiencies under various conditions were determined by collecting (224)Ra recoiling out of (228)Th electrodeposited and precipitated sources. The pressure in the apparatus (vacuum or 1 atm of N2 gas) affected the variations of the collection efficiencies depending on the negative voltage applied to the collector. The maximum values of the collection efficiencies were mainly affected by the thickness of the (228)Th sources. From these results, the suitable conditions of the (239)Pu sources for preparation of (235m)U were determined. In addition, dissolution efficiencies were determined by washing collected (224)Ra with solutions. When (224)Ra was collected in 1 atm of N2 gas and dissolved with polar solutions such as water, the dissolution efficiencies were nearly 100%. The method of rapid dissolution of recoil products would be applicable to rapid preparation of short-lived (235m)U samples for various chemical forms.

6.
Rev Sci Instrum ; 87(5): 053309, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-27250416

RESUMO

For evaluation of on-site dosimetry and process design in industrial use of ultra-low energy electron beam (ULEB) processes, we evaluate the energy deposition using a thin radiochromic film and a Monte Carlo simulation. The response of film dosimeter was calibrated using a high energy electron beam with an acceleration voltage of 2 MV and alanine dosimeters with uncertainty of 11% at coverage factor 2. Using this response function, the results of absorbed dose measurements for ULEB were evaluated from 10 kGy to 100 kGy as a relative dose. The deviation between the responses of deposit energy on the films and Monte Carlo simulations was within 15%. As far as this limitation, relative dose estimation using thin film dosimeters with response function obtained by high energy electron irradiation and simulation results is effective for ULEB irradiation processes management.

7.
Biochim Biophys Acta ; 1233(1): 57-67, 1995 Jan 26.
Artigo em Inglês | MEDLINE | ID: mdl-7833350

RESUMO

Characteristics of specific 125I-omega-conotoxin GVIA (125I-omega-CgTX) binding and 125I-omega-CgTX labeling using bifunctional crosslinkers were systematically investigated in crude membranes from chick whole brain. Aminoglycosides and dynorphine A (1-13) inhibited the specific binding of 125I-omega-CgTX, but not that of the L-type calcium ion channel antagonist [3H](+)PN200-110. It seems likely that the inhibitory effect of dynorphine A (1-13) does not involve kappa-opiate receptors, based on results with the opiate receptor antagonist naloxone and the kappa-opiate receptor agonist U50488H. Spider venom, Cd2+ and La3+ inhibited the specific binding of 125I-omega-CgTX, as well as that of [3H](+)PN200-110. Various L-type Ca2+ channel antagonists did not affect the specific binding of 125I-omega-CgTX. 125I-omega-CgTX specifically labeled 135 kDa and 215 kDa bands in crude membranes under reduced and non-reduced conditions, respectively. The crosslinker disuccinimidyl suberate (DSS) yielded better 125I-omega-CgTX labeling than the other two crosslinkers tested. We investigated the effect of various Ca2+ channel antagonists on 125I-omega-CgTX labeling with DSS in detail, and found that there is a strong correlation between the effects of Ca2+ channel antagonists on 125I-omega-CgTX labeling of the 135 kDa band and specific 125I-omega-CgTX binding. These results suggest that aminoglycosides and dynorphine A (1-13) are specific inhibitors of specific 125I-omega-CgTX binding, and that labeling of the 135 kDa band with 125I-omega-CgTX using DSS involves the specific binding sites of 125I-omega-CgTX, perhaps including one of the neuronal N-type Ca2+ channel subunits in the crude membranes.


Assuntos
Canais de Cálcio/metabolismo , Venenos de Moluscos/metabolismo , Peptídeos/metabolismo , Marcadores de Afinidade , Animais , Encéfalo , Agonistas dos Canais de Cálcio/farmacologia , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/efeitos dos fármacos , Galinhas , Reagentes de Ligações Cruzadas/farmacologia , Técnicas In Vitro , Indicadores e Reagentes/farmacologia , Radioisótopos do Iodo , Isradipino/metabolismo , ômega-Conotoxina GVIA
8.
Intern Med ; 36(11): 810-4, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9392355

RESUMO

Pyogenic osteomyelitis is often accompanied by diabetes, but the disease in the clavicula has rarely been reported. We describe an unusual case of a 53-year-old man with poorly controlled non-insulin-dependent diabetes mellitus who presented with pyogenic clavicular osteomyelitis and developed DIC and acute renal failure. A 67Ga scintigram revealed an abnormal accumulation of the isotope in the right clavicula, where magnetic resonance imaging (MRI) showed inflammatory changes. This suggests that a 67Ga scintigram and MRI are of clinical value for the early diagnosis of the disease. Antibiotic chemotherapy with gamma-globulin and gebexate mesilate, and hemodialysis almost cured his serious condition.


Assuntos
Injúria Renal Aguda/complicações , Clavícula , Diabetes Mellitus Tipo 2/complicações , Coagulação Intravascular Disseminada/complicações , Osteomielite/complicações , Injúria Renal Aguda/terapia , Antibacterianos , Anticoagulantes/uso terapêutico , Clavícula/diagnóstico por imagem , Diabetes Mellitus Tipo 2/tratamento farmacológico , Coagulação Intravascular Disseminada/tratamento farmacológico , Quimioterapia Combinada/uso terapêutico , Seguimentos , Gabexato/uso terapêutico , Radioisótopos de Gálio , Humanos , Hipoglicemiantes/uso terapêutico , Imunização Passiva/métodos , Insulina/uso terapêutico , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Osteomielite/diagnóstico , Osteomielite/terapia , Cintilografia , Diálise Renal , gama-Globulinas/uso terapêutico
9.
Intern Med ; 38(10): 833-6, 1999 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10526951

RESUMO

Mycobacterium fortuitum is a well-documented cause of nosocomial infection. However, no studies have reported peritonitis with M. fortuitum as a postoperative complication. We describe a case of peritonitis with M. fortuitum biovariant peregrinum following gastric cancer surgery. Gram-positive bacterial infection coexisted. Although the source of the infection was unclear, the patient was successfully treated with drainage tube exchange and combination therapy consisting of sparfloxacin, clarithromycin, and imipenem/cilastatin sodium. Thus for postoperative infectious pathogens, not only bacteria but also nontuberculous mycobacteria should be considered.


Assuntos
Adenocarcinoma/cirurgia , Infecção Hospitalar/microbiologia , Neoplasias Gastrointestinais/cirurgia , Infecções por Mycobacterium não Tuberculosas/etiologia , Mycobacterium fortuitum/isolamento & purificação , Peritonite/microbiologia , Complicações Pós-Operatórias/microbiologia , Idoso , Idoso de 80 Anos ou mais , Antibacterianos , Bactérias/isolamento & purificação , Terapia Combinada , Infecção Hospitalar/terapia , Drenagem , Quimioterapia Combinada/uso terapêutico , Feminino , Humanos , Infecções por Mycobacterium não Tuberculosas/terapia , Peritonite/terapia , Complicações Pós-Operatórias/terapia
10.
Intern Med ; 37(2): 169-73, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9550599

RESUMO

A case of rhabdomyolysis after a possible viral infection and the use of a cold medication is reported. A 41-year-old man who presented with dysarthria, dysphagia, progressive weakness of his muscles and a high grade fever was admitted. He suffered from massive rhabdomyolysis, acute renal failure, and bronchopneumonia. Hemodialysis, antibiotics, and hydration therapy were effective in the treatment of his illness. Although the cause of the rhabdomyolysis was not completely clear, he was subsequently shown to be susceptible to malignant hyperthermia (MH) based on the results of a caffeine-halothane contracture test. When a mild recurrence occurred during a follow-up muscle biopsy, intravenous dantrolene sodium was administered and he improved immediately. This case suggests that MH should be considered in patients with rhabdomyolysis when the cause is unclear. The caffeine-halothane contracture test may also be helpful in the diagnosis.


Assuntos
Hipertermia Maligna/complicações , Rabdomiólise/etiologia , Viroses/complicações , Adulto , Cafeína , Clorfeniramina/efeitos adversos , Resfriado Comum/tratamento farmacológico , Dantroleno/uso terapêutico , Halotano , Humanos , Técnicas In Vitro , Masculino , Hipertermia Maligna/diagnóstico , Hipertermia Maligna/fisiopatologia , Contração Muscular/efeitos dos fármacos , Medicamentos sem Prescrição/efeitos adversos , Fenilefrina/efeitos adversos , Fenilpropanolamina/efeitos adversos , Rabdomiólise/diagnóstico , Rabdomiólise/tratamento farmacológico
11.
Intern Med ; 40(8): 779-82, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11518124

RESUMO

We describe a case of vinorelbine tartrate (VNR) associated acute respiratory failure. A 65-year-old man with non-small cell lung cancer developed acute respiratory failure 50 minutes after his first infusion with VNR in combination with mitomycin-C. The patient was treated with furosemide, dopamine and high-dose methylprednisolone, and recovered with no discernible sequelae. Although clinical trials have shown that respiratory symptoms associated with VNR treatment have only rarely been observed and the putative mechanism remains to be elucidated, patients receiving VNR should be monitored carefully, particularly in the first few hours after intravenous administration.


Assuntos
Antineoplásicos Fitogênicos/efeitos adversos , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Insuficiência Respiratória/induzido quimicamente , Vimblastina/análogos & derivados , Vimblastina/efeitos adversos , Doença Aguda , Idoso , Antibióticos Antineoplásicos/administração & dosagem , Antineoplásicos Fitogênicos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Humanos , Masculino , Mitomicina/administração & dosagem , Insuficiência Respiratória/complicações , Resultado do Tratamento , Vimblastina/uso terapêutico , Vinorelbina
12.
Kekkaku ; 68(1): 23-9, 1993 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-8437420

RESUMO

A clinical course of pulmonary tuberculosis was reported about adverse reaction of anti-tuberculous chemotherapy. A fifty-eight-year-old male patient was complicated with agranulocytosis induced by RFP, hepatic dysfunction and systemic eruption induced by INH, and high fever induced by SM. Adjuvant therapy with Shosaikoto and Hocheukito suppressed INH induced hepato-dermatological toxicosis moderately and suppressed SM induced high fever completely. By these anti-allergic therapy, combined chemotherapy with SM, EB, PAS and PZA became possible during more than six months, and chemotherapeutic effect was marked. This case report suggested possibility and significance of those Kampo agents against serious allergic reaction complicated with the chemotherapy for pulmonary tuberculosis.


Assuntos
Antibióticos Antituberculose/efeitos adversos , Hipersensibilidade a Drogas/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , Tuberculose Pulmonar/tratamento farmacológico , Humanos , Masculino , Pessoa de Meia-Idade , Tuberculose Pulmonar/imunologia
13.
Nihon Jinzo Gakkai Shi ; 31(9): 897-903, 1989 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-2531243

RESUMO

Complement system takes an important role in the pathogenesis of immune complex glomerulonephritis. In this study the precise changes of serum complement and its deposition in the glomeruli were investigated in the mice models induced with cationized bovine gamma-globulin (CBGG). Balb/c mice preimmunized with CBGG were injected intravenously with CBGG three times every 24 hours. Proteinuria and hypoalbuminemia have developed from day 3 until the death on day 9-13 of progressed azotemia. This nephritis resembled to mesangial proliferative glomerulonephritis histopathologically. Immunofluorescent study revealed granular deposits of CBGG, IgG, A, M and C3 along the glomerular capillary loop. Serum C3 decreased to about 50% of normal controls within 1 hour after challenge of antigen and plasma C3 conversion evaluated by crossed-immunoelectrophoresis, occurred in accordance with C3 reduction and then decreased. Immunofluorescent study showed a big difference in the mode of deposition among IgG, CBGG and C3. The most intense deposits of C3 in the glomeruli were seen 12 hours after challenge of CBGG, and then gradually decreased until the next challenge. IgG and CBGG antigen deposited most intensely soon after the challenge of antigen, and gradually decreased. These results led us to conclude that there existed two phases of complement activation in this immune complex induced mice glomerulonephritis; an early phase activation of complement by antigen-antibody complexes in the circulation and later phase activation of complement by immune complexes after deposition of them in situ glomeruli.


Assuntos
Antígenos/imunologia , Complemento C3/análise , Glomerulonefrite/imunologia , Doenças do Complexo Imune/imunologia , Animais , Cátions , Bovinos , Feminino , Camundongos , Camundongos Endogâmicos BALB C
14.
Nihon Jinzo Gakkai Shi ; 33(3): 231-7, 1991 Mar.
Artigo em Japonês | MEDLINE | ID: mdl-1712051

RESUMO

Using a murine acute serum sickness model caused by cationized bovine gamma-globulin (CBGG), the histological findings, accumulation of CBGG in the organs and the effect of decomplementation for the clearance of immune complex (IC) were investigated. The accumulation of CBGG increased in the lungs in the presence of anti-CBGG antibody 1 hour after injection of CBGG, but did not change in the kidneys. This suggests that CBGG forms IC in situ in the kidneys, and that circulating IC accumulates in the lungs. Decomplementation did not influence the uptake of CBGG immediately after challenge but delayed the clearance of CBGG in the kidneys, lungs, liver and spleen. A beneficial role of the complement system in the clearance of IC even for those formed in situ was recognized. Histological changes, cellular infiltration and microvascular destruction, evoked in the lungs in this experimental model immediately after challenge, were not seen in the kidney, suggesting the different modes of complement activation in these organs.


Assuntos
Complexo Antígeno-Anticorpo/metabolismo , Complemento C3/metabolismo , Doença do Soro/imunologia , gama-Globulinas/imunologia , Animais , Feminino , Rim/imunologia , Cinética , Pulmão/imunologia , Camundongos , Camundongos Endogâmicos BALB C
15.
Nihon Jinzo Gakkai Shi ; 32(1): 19-24, 1990 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-2348571

RESUMO

The kinetics of hemodialysis-induced leukopenia and generation of complement fragments including C3a, C5a, C4d, iC3b and Bb were investigated in 14 patients during hemodialysis using cellulose acetate (CA), cuprophan (Cu) and ethylenevinyl alcohol (EVA) membranes. A marked leukopenia in the first 15 minutes was observed in CA and Cu. Plasma C3a levels were higher in CA than in Cu and EVA. Plasma C5a levels were higher in CA and Cu than in EVA. There was a negative correlation between the white blood cell counts and plasma C5a levels at 15 minutes (gamma = -0.85, p less than 0.001). Plasma C4d levels showed no increase in all membranes. Plasma iC3b levels were higher significantly in Cu than in CA and EVA. Plasma Bb levels in the first 15 minutes increased significantly in all membranes, and furthermore continued to increase till the end of hemodialysis in CA and Cu. This study revealed that all the membranes tested activated the complement via the alternative pathway to produce Bb, iC3b, C3a and C5a. C5a was thought to take an important role in transient leukopenia. Furthermore, Bb was accumulated during hemodialysis in CA and Cu, and its biological effects on patients undergoing hemodialysis should be studied.


Assuntos
Proteínas do Sistema Complemento/metabolismo , Falência Renal Crônica/sangue , Fragmentos de Peptídeos/metabolismo , Diálise Renal , Adulto , Idoso , Idoso de 80 Anos ou mais , Ensaio de Atividade Hemolítica de Complemento , Via Alternativa do Complemento , Feminino , Humanos , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade
16.
Nihon Jinzo Gakkai Shi ; 33(7): 679-84, 1991 Jul.
Artigo em Japonês | MEDLINE | ID: mdl-1749118

RESUMO

The expression of complement receptor type 1 (CR1) and type 3 (CR3) on polymorphonuclear leukocytes (PMNs) and generation of complement fragments, C3a, C5a, C4d, iC3b and Bb, were studied in patients during hemodialysis using cuprammonium rayon (Cu) membranes. Furthermore, the relation between the expression of CR1 and CR3 on PMNs from healthy donors and complement fragments was investigated. The expression of CR1 and CR3 on PMNs increased during hemodialysis. Plasma C3a, C5a and iC3b levels increased in the first 15 minutes and then decreased at 120 minutes of dialysis. But plasma Bb level remained high until the end of hemodialysis. Purified Bb had no effect on the expression of CR1 and CR3 on PMNs, but C5a augmented those expression in vitro. Nafamostat mesilate, an artificial proteinase inhibitor, inhibited augmentation of complement receptors on PMNs in concentration dependent fashion. C5a generated through the activation of complement was thought to take an important role in the increased expression of CR1 and CR3 on PMNs.


Assuntos
Complemento C3a/análise , Complemento C4b , Complemento C5a/análise , Neutrófilos/imunologia , Receptores de Complemento/análise , Diálise Renal , Idoso , Idoso de 80 Anos ou mais , Benzamidinas , Células Cultivadas , Doença Crônica , Complemento C3/metabolismo , Complemento C4/análise , Glomerulonefrite/imunologia , Glomerulonefrite/terapia , Guanidinas/farmacologia , Humanos , Masculino , Pessoa de Meia-Idade , Fragmentos de Peptídeos/análise
17.
Arerugi ; 42(11): 1650-6, 1993 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-8279965

RESUMO

Serial changes of circulating immune complexes and anti-mite specific IgG antibody in the peripheral blood were measured eight times in six status asthmatics treated with high doses of methylprednisolone (MPS). Circulating immune complexes decreased to normal levels three hours after MPS administration. By contrast, anti-mite specific IgG antibody increased to beyond the normal range 14 days after MPS administration. Serum levels of IgE and allergen specific IgG4 antibody did not show any significant changes. In vitro experiments, circulating immune complexes in the sampled sera were decreased by an absorption test with anti-mite specific IgG antibody, and increased by reaction with an adequate volume of mite allergen. These facts indicate that circulating immune complexes are an anti-complementary factor working on the complement system, as previously reported, and that mite allergen and anti-mite IgG antibody relate to their conformation in status asthmatics. Clinically, MPS might possess an inhibitory effects on the formation of immune complexes and/or accelerate complement-dependent solubilization of antigen-antibody complexes, so that anti-mite specific IgG antibody increased markedly in the peripheral blood.


Assuntos
Complexo Antígeno-Anticorpo/sangue , Proteínas Inativadoras do Complemento/metabolismo , Imunoglobulina G/sangue , Metilprednisolona/uso terapêutico , Ácaros/imunologia , Estado Asmático/imunologia , Adulto , Idoso , Alérgenos/imunologia , Animais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estado Asmático/tratamento farmacológico
18.
Arerugi ; 42(10): 1616-22, 1993 Oct.
Artigo em Japonês | MEDLINE | ID: mdl-8250724

RESUMO

Acute hemorrhagic alveolitis was elicited in the lungs of guinea pigs by aerosol challenge with sonicated P. aeruginosa whole cells. Histological findings showed the severe inflammatory changes, which were characterized by the inflammatory infiltration of alveolar macrophages (AM), polymorphonuclear leukocytes (PMN) and eosinophils in the peribronchial and the alveolar space at 8 hours after the challenge. A marked increase of PMN as well as AM was noted in the bronchial alveolar lavage fluid (BALF) at 8 hours after the challenge and the increase of the numbers of AM and PMN in the BALF remained until 24 hours after challenge. The complement titer (CH50) and C3 component in the serum decreased at the early stage, and CH50 maintained low level and C3 component increased gradually. Polyethyleneglycol precipitation-complement consumption test (PEG-CC) of the BALF showed the existence of immune complexes formed in the airway after aerosol inhalation. These data suggest that the immune complexes of P. aeruginosa activate the complement system in the lungs, which is followed by the infiltration of inflammatory cells. Guinea pigs which were pretreated with cobra venom factor significantly reduced the extent of the inflammatory changes in the lungs. The results suggests that the complement system might act as an important factor of the acute lung injury in this model.


Assuntos
Pulmão/patologia , Pseudomonas aeruginosa/imunologia , Administração por Inalação , Aerossóis , Animais , Complexo Antígeno-Anticorpo/imunologia , Proteínas do Sistema Complemento/metabolismo , Modelos Animais de Doenças , Cobaias , Pulmão/imunologia , Masculino , Pseudomonas aeruginosa/citologia , Sonicação
19.
Arerugi ; 41(11): 1567-74, 1992 Nov.
Artigo em Japonês | MEDLINE | ID: mdl-1492790

RESUMO

Complement system was investigated in 7 patients with status asthmatics treated with large doses of methylprednisolone (MPS). Complement hemolytic activities, complement protein profile, complement fragments and circulating immune complexes were measured before, 3 and 8 hours after and 14 days after MPS administration. MPS normalized C4 and C1INH activities 6 hours after administration. MPS also decreased ACH50 6 hours after administration and D activity 3 and 6 hours after, but these activities recovered to their previous normal range within 14 days. P and H were decreased at each measurement time, and C1s was transiently decreased 6 hours after MPS administration. Complement fragment iC3b was increased at each measurement time, but fragment Bb tended to be decreased 14 days after MPS administration. The increment of anaphylatoxin C3a recovered to normal 14 days after MPS administration. In vitro experiments, MPS inhibited D and C1s activation directly, and decreased the decay of B and C4. Inhibition of C1s might also increase C1INH activity clinically. These results clarified that the alternative complement pathway was activated, and suggested that the C1 bypass pathway might be also activated in status asthmatics. It was further considered that these anti-complementary effects induced by MPS, brought about an improvement in asthmatic symptoms. Studies to identify the complement activators continued, and circulating immune complexes may possibly be one of those agents activating complement cascade.


Assuntos
Proteínas do Sistema Complemento/metabolismo , Metilprednisolona/uso terapêutico , Estado Asmático/imunologia , Adulto , Idoso , Complexo Antígeno-Anticorpo/metabolismo , Via Alternativa do Complemento/efeitos dos fármacos , Via Clássica do Complemento/efeitos dos fármacos , Feminino , Humanos , Masculino , Metilprednisolona/farmacologia , Pessoa de Meia-Idade , Estado Asmático/tratamento farmacológico
20.
Arerugi ; 41(9): 1398-404, 1992 Sep.
Artigo em Japonês | MEDLINE | ID: mdl-1444833

RESUMO

From a clinical study it was found that serum ClINH activity increased 6 hours after methylprednisolone (MP) pulse therapy in all the patients we studied with connective tissue diseases. Furthermore plasma ClINH-Cls complex decreased after pulse therapy. These phenomena lead us to investigate the effect of MP on Cls. 1) When a constant amount of Cls (8 micrograms/ml) was incubated with several concentrations of MP (2-50 mg/ml), the Cls activity of consuming C4 hemolysis was inhibited by MP in a dose-dependent manner. 2) MP inhibited consumption of C2 as well as C4 by Cls in a dose-dependent manner, even when MP had been removed by dialysis following incubation with Cls. These experimental data suggested that the trace amounts of Cls generated by immune complexes could be inhibited by long circulation of MP even at low concentrations in vivo, and resulted in a decrease of ClINH consumption and ClINH-Cls complex formation. These results indicated that the inhibition of Cls activity is one of the most important mechanisms in the process of the anti-inflammatory effect of MP in vivo.


Assuntos
Proteínas Inativadoras do Complemento 1/metabolismo , Metilprednisolona/farmacologia , Proteínas Inativadoras do Complemento 1/efeitos dos fármacos , Complemento C1s/metabolismo , Doenças do Tecido Conjuntivo/tratamento farmacológico , Doenças do Tecido Conjuntivo/imunologia , Esquema de Medicação , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA